In fact, a reversal of fibrosis may be possible, which has been documented in animal models of cardiomyopathy [98,99] where the AT1 antagonist losartan reversed fibrosis and suppressed TGF-β1 expression. This evidence concerns the gene TGFB1 and cardiomyopathy.